Generation, function, and prognostic utility of somatic mitochondrial DNA mutations in cancer

Environmental and Molecular Mutagenesis

Volumn 51, Issue 5, 2010, Pages 427-439

  Kulawiec, Mariola ^a   Salk, Jesse J ^b   Ericson, Nolan G ^a   Wanagat, Jonathan ^c   Bielas, Jason H ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CHLORAMPHENICOL; MITOCHONDRIAL DNA; MUTANT PROTEIN;

BASE PAIRING; BREAST CANCER; CANCER CELL; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER RECURRENCE; CANCER RESISTANCE; CARCINOGENESIS; CELL FREE SYSTEM; CELL LINEAGE; CELL PROLIFERATION; CIRCULATING TUMOR CELL; CLINICAL TRIAL; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE FREE SURVIVAL; DNA DAMAGE; GASTROINTESTINAL CARCINOMA; GENE DELETION; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; KIDNEY CANCER; LIVER CANCER; LIVER CELL CARCINOMA; LUNG CANCER; MELANOMA; META ANALYSIS; NEOPLASM; OUTCOME ASSESSMENT; OVARY CANCER; PHENOTYPE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; PROTEIN FUNCTION; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS; SKIN CANCER; SOLID TUMOR; SOMATIC MUTATION; STOMACH CANCER; SYSTEMATIC REVIEW; THYROID CANCER; THYROID PAPILLARY CARCINOMA; UTERINE CERVIX CANCER; UTERUS CANCER;

DNA DAMAGE; DNA, MITOCHONDRIAL; HUMANS; MUTATION; NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77953490673     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20582     Document Type: Review

References (92)

1. Abu-Amero K, Zou M, Shi Y. 2004. Mitochondrial A135149 mutation without MELAS but in association with papillary thyroid carcinoma. Clin Genet 66:569-570.
2. Abu-Amero KK, Alzahrani AS, Zou M, Shi Y. 2005. High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines. Oncogene 24:1455-1460.
3. Allen JA, Coombs MM. 1980. Covalent binding of polycyclic aromatic compounds to mitochondrial and nuclear DNA. Nature 287:244-245.
4. Alonso A, Martin P, Albarran C, Aquilera B, Garcia O, Guzman A, Oliva H, Sancho M. 1997. Detection of somatic mutations in the mitochondrial DNA control region of colorectal and gastric tumors by heteroduplex and single-strand conformation analysis. Electrophoresis 18:682-685.
5. Asami S, Manabe H, Miyake J, Tsurudome Y, Hirano T, Yamaguchi R, Itoh H, Kasai H. 1997. Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung. Carcinogenesis 18:1763-1766.
6. Bielas JH, Loeb KR, Rubin BP, True LD, Loeb LA. 2006. Human cancers express a mutator phenotype. Proc Natl Acad Sci USA 103: 18238-18242.
7. Bielas JH, Loeb LA. 2005. Quantification of random genomic mutations. Nat Methods 2:285-290.
8. Bragoszewski P, Kupryjanczyk J, Bartnik E, Rachinger A, Ostrowski J. 2008. Limited clinical relevance of mitochondrial DNA mutation and gene expression analyses in ovarian cancer. BMC Cancer 8:292
9. Chang HW, Lee SM, Goodman SN, Singer G, Cho SK, Sokoll LJ, Montz FJ, Roden R, Zhang Z, Chan DW, Kurman RJ, Shih IeM. 2002. Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer. J Natl Cancer Inst 94:1697-1703.
10. Chatterjee A, Mambo E, Sidransky D. 2006. Mitochondrial DNA mutations in human cancer. Oncogene 25:4663-4674.
11. Coller HA, Khrapko K, Bodyak ND, Nekhaeva E, Herrero-Jimenez P, Thilly WG. 2001. High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat Genet 28:147-150.
12. Copeland. 2002. Mitochondrial DNA, methods and protocols. Methods Mol Biol (Humana Press) 197:v-vi.
13. Corona P, Antozzi C, Carrara F, D'Incerti L, Lamantea E, Tiranti V, Zeviani M. 2001. A novel mtDNA mutation in the ND5 subunit of complex I in two MELAS patients. Ann Neurol 49:106-110.
14. Dean SW, Brooks TM, Burlinson B, Mirsalis J, Myhr B, Recio L, Thybaud V. 1999. Transgenic mouse mutation assay systems can play an important role in regulatory mutagenicity testing in vivo for the detection of site-of-contact mutagens. Mutagen 14:141-151.
15. Deichmann M, Kahle B, Benner A, Thome M, Helmke B, Naher H. 2004. Somatic mitochondrial mutations in melanoma resection specimens. Int J Oncol 24:137-141.
16. Ding Z, Ji J, Chen G, Fang H, Yan S, Shen L, Wei J, Yang K, Lu J, Bai Y. 2009. Analysis of mitochondrial DNA mutations in D-loop region in thyroid lesions. Biochim Biophys Acta 1800:271-274.
17. Ellinger J, Bastian PJ, Ellinger N, Kahl P, Perabo FG, Buttner R, Muller SC, Ruecker A. 2008. Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer: A prognostic entity. Cancer Lett 264:274-280.
18. Ellinger J, Wittkamp V, Albers P, Perabo FG, Mueller SC, von Ruecker A, Bastian PJ. 2009. Cell-free circulating DNA: Diagnostic value in patients with testicular germ cell cancer. J Urol 181:363-371.
19. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, Jen J, Sidransky D. 2000. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287:2017-2019.
20. Gasparre G, Hervouet E, de Laplanche E, Demont J, Pennisi LF, Colombel M, Mege-Lechevallier F, Scoazec JY, Bonora E, Smeets R, Gasparre G, Smeitink J, Lazar V, Lespinasse J, Giraud S, Godinot C, Romeo G, Simonnet H. 2008. Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma. Hum Mol Genet 17:986-995.
21. Gekeler J, Zsurka G, Kunz WS, Preuss SF, Klussmann JP, Guntinas-Lichius O, Wiesner RJ. 2009. Clonal expansion of different mtDNA variants without selective advantage in solid tumors. Mutat Res 662:28-32.
22. Gomez-Zaera M, Abril J, Gonzalez L, Aguilo F, Condom E, Nadal M, Nunes V. 2006. Identification of somatic and germline mitochondrial DNA sequence variants in prostate cancer patients. Mutat Res 595(1-2):42-51.
23. Gormally E, Caboux E, Vineis P, Hainaut P. 2007. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significance. Mutat Res 635(2-3):105-117.
24. Habano W, Sugai T, Yoshida T, Nakamura S. 1999. Mitochondrial gene mutation, but not large-scale deletion, is a feature of colorectal carcinomas with mitochondrial microsatellite instability. Int J Cancer 83:625-629.
25. Hibi K, Nakayama H, Yamazaki T, Takase T, Taguchi M, Kasai Y, Ito K, Akiyama S, Nakao A. 2001. Detection of mitochondrial DNA alterations in primary tumors and corresponding serum of colorectal cancer patients. Int J Cancer 94:429-431.
26. Horton TM, Petros JA, Heddi A, Shoffner J, Kaufman AE, Graham SD Jr., Gramlich T, Wallace DC. 1996. Novel mitochondrial DNA deletion found in a renal cell carcinoma. Genes Chromosomes Cancer 15:95-101.
27. Huang ZH, Li LH, Hua D. 2006. Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients. Cancer Lett 243:64-70.
28. Hung WY, Lin JC, Lee LM, Wu CW, Tseng LM, Yin PH, Chi CW, Lee HC. 2008. Tandem duplication/triplication correlated with polycytosine stretch variation in human mitochondrial DNA D-loop region. Mutagen 23:137-142.
29. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y, Hayashi J. 2008. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320:661-664.
30. Jacobs HT. 2003. The mitochondrial theory of aging: Dead or alive? Aging Cell 2:11-17.
31. Jaruga P, Zastawny TH, Skokowski J, Dizdaroglu M, Olinski R. 1994. Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer. FEBS Lett 341:59-64.
32. Jeronimo C, Nomoto S, Caballero OL, Usadel H, Henrique R, Varzim G, Oliveira J, Lopes C, Fliss MS, Sidransky D. 2001. Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 20:5195-5198.
33. Jin X, Zhang J, Gao Y, Ding K, Wang N, Zhou D, Jen J, Cheng S. 2007. Relationship between mitochondrial DNA mutations and clinical characteristics in human lung cancer. Mitochondrion 7:347-353.
34. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T, Nikolsky Y, Hartigan J, Smith DR, Hidalgo M, Leach SD, Klein AP, Jaffee EM, Goggins M, Maitra A, Iacobuzio-Donahue C, Eshleman JR, Kern SE, Hruban RH, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW. 2008. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321:1801-1806.
35. Jung K, Stephan C, Lewandowski M, Klotzek S, Jung M, Kristiansen G, Lein M, Loening SA, Schnorr D. 2004. Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancer. Cancer Lett 205:173-180.
36. Khrapko K, Coller HA, Andre PC, Li XC, Hanekamp JS, Thilly WG. 1997. Mitochondrial mutational spectra in human cells and tissues. Proc Natl Acad Sci USA 94:13798-13803.
37. Kose K, Hiyama T, Tanaka S, Yoshihara M, Yasui W, Chayama K. 2005. Somatic mutations of mitochondrial DNA in digestive tract cancers. J Gastroenterol Hepatol 20:1679-1684.
38. Kulawiec M, Owens KM, Singh KK. 2009. Cancer cell mitochondria confer apoptosis resistance and promote metastasis. Cancer Biol Ther 8:1378-1385.
39. Lee HC, Li SH, Lin JC, Wu CC, Yeh DC, Wei YH. 2004. Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat Res 547(1-2):71-78.
40. Lee HC, Yin PH, Lin JC, Wu CC, Chen CY, Wu CW, Chi CW, Tam TN, Wei YH. 2005. Mitochondrial genome instability and mtDNA depletion in human cancers. Ann N Y Acad Sci 1042: 109-122.
41. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. 1977. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37:646-650. (Pubitemid 8051621)
42. Li HX, Zhong S, Li CH. 2003. Study on the mitochondrion DNA mutation in tumor tissues of gynecologic oncology patients. Zhonghua Fu Chan Ke Za Zhi 38:290-293.
43. Lievre A, Chapusot C, Bouvier AM, Zinzindohoue F, Piard F, Roignot P, Arnould L, Beaune P, Faivre J, Laurent-Puig P. 2005. Clinical value of mitochondrial mutations in colorectal cancer. J Clin Oncol 23:3517-3525.
44. Liu VW, Yang HJ, Wang Y, Tsang PC, Cheung AN, Chiu PM, Ng TY, Wong LC, Nagley P, Ngan HY. 2003. High frequency of mitochondrial genome instability in human endometrial carcinomas. Br J Cancer 89:697-701.
45. Lorenc A, Bryk J, Golik P, Kupryjanczyk J, Ostrowski J, Pronicki M, Semczuk A, Szolkowska M, Bartnik E. 2003. Homoplasmic MELAS A3243G mtDNA mutation in a colon cancer sample. Mitochondrion 3:119-124.
46. Maximo V, Soares P, Lima J, Cameselle-Teijeiro J, Sobrinho-Simoes M. 2002. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: A study with emphasis on Hurthle cell tumors. Am J Pathol 160:1857-1865. (Pubitemid 34525665)
47. Maximo V, Lima J, Soares P, Botelho T, Gomes L, Sobrinho-Simoes M. 2005. Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy. Mitochondrion 5:333-340.
48. Mayr JA, Meierhofer D, Zimmermann F, Feichtinger R, Kogler C, Ratschek M, Schmeller N, Sperl W, Kofler B. 2008. Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma. Clin Cancer Res 14:2270-2275.
49. Michikawa Y, Mazzucchelli F, Bresolin N, Scarlato G, Attardi G. 1999. Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science 286:774-779. (Pubitemid 129515725)
50. Murata T, Hibasami H, Maekawa S, Tagawa T, Nakashima K. 1990. Preferential binding of cisplatin to mitochondrial DNA, suppression of ATP generation in human malignant melanoma cells. Biochem Int 20:949-955. (Pubitemid 20142738)
51. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkins RG, Haber DA, Toner M. 2007. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450:1235-1239.
52. Nagy A, Wilhelm M, Sukosd F, Ljungberg B, Kovacs G. 2002. Somatic mitochondrial DNA mutations in human chromophobe renal cell carcinomas. Genes Chromosomes Cancer 35:256-260.
53. Niranjan BG, Bhat NK, Avadhani NG. 1982. Preferential attack of mitochondrial DNA by aflatoxin B1 during hepatocarcinogenesis. Science 215:73-75.
54. Nishikawa M, Nishiguchi S, Shiomi S, Tamori A, Koh N, Takeda T, Kubo S, Hirohashi K, Kinoshita H, Sato E, Inoue M. 2001. Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma. Cancer Res 61:1843-1845.
55. Nomoto S, Yamashita K, Koshikawa K, Nakao A, Sidransky D. 2002. Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma. Clin Cancer Res 8:481-487. (Pubitemid 34193968)
56. Pantel K, Brakenhoff RH, Brandt B. 2008. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8:329-340.
57. Parr RL, Dakubo GD, Crandall KA, Maki J, Reguly B, Aguirre A, Wittock R, Robinson K, Alexander JS, Birch-Machin MA Abdel-Malak M, Froberg MK, Diamandis EP, Thayer RE. 2006. Somatic mitochondrial DNA mutations in prostate cancer and normal appearing adjacent glands in comparison to age-matched prostate samples without malignant histology. J Mol Diagn 8:312-319.
58. Parrella P, Xiao Y, Fliss M, Sanchez-Cespedes M, Mazzarelli P, Rinaldi M, Nicol T, Gabrielson E, Cuomo C, Cohen D, Pandit S, Spencer M, Rabitti C, Fazio V M, Sidransky D. 2001. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res 61:7623-7626.
59. Parsons BL, Heflich RH. 1997. Genotypic selection methods for the direct analysis of point mutations. Mutat Res 387:97-121.
60. Pejovic T, Ladner D, Intengan M, Zheng K, Fairchild T, Dillon D, Easley S, Marchetti D, Schwartz P, Lele S, Costa J, Odunsi K. 2004. Somatic D-loop mitochondrial DNA mutations are frequent in uterine serous carcinoma. Eur J Cancer 40:2519-2524.
61. Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, Lim S, Issa MM, Flanders WD, Hosseini SH, Marshall FF, Wallace DC. 2005. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 102:719-724.
62. Poetsch M, Dittberner T, Petersmann A, Woenckhaus C. 2004. Mitochondrial DNA instability in malignant melanoma of the skin is mostly restricted to nodular and metastatic stages. Melanoma Res 14:501-508.
63. Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD, Trush MA, Kinzler KW, Vogelstein B. 1998. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 20:291-293.
64. Salas A, Yao YG, Macaulay V, Vega A, Carracedo A, Bandelt HJ. 2005. A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med 2:e296
65. Selvanayagam P, Rajaraman S. 1996. Detection of mitochondrial genome depletion by a novel cDNA in renal cell carcinoma. Lab Invest 74:592-599. (Pubitemid 26105720)
66. Semczuk A, Lorenc A, Putowski L, Futyma K, Bryk J, Miotla P, Bartnik E. 2006. Clinicoprognostical features of endometrial cancer patients with somatic mtDNA mutations. Oncol Rep 16:1041-1045.
67. Shi H, Pan L, Song T. 2009. Impact of platinum on the whole mitochondrial genome of ovarian carcinomas both in vivo and in vitro. Int J Gynecol Cancer 19:423-430.
68. Shidara Y, Yamagata K, Kanamori T, Nakano K, Kwong JQ, Manfredi G, Oda H, Ohta S. 2005. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res 65:1655-63.
69. Sjöblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE. 2006. The consensus coding sequences of human breast and colorectal cancers. Science 314:268-274.
70. Sozzi G, Conte D, Mariani L, Lo Vullo S, Roz L, Lombardo C, Pierotti MA, Tavecchio L. 2001. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res 61:4675-4678. (Pubitemid 32691874)
71. Suzuki M, Toyooka S, Miyajima K, Iizasa T, Fujisawa T, Bekele NB, Gazdar AF. 2003. Alterations in the mitochondrial displacement loop in lung cancers. Clin Cancer Res 9:5636-5641. (Pubitemid 37499485)
72. Takeuchi H, Fujimoto A, Hoon DS. 2004. Detection of mitochondrial DNA alterations in plasma of malignant melanoma patients. Ann N Y Acad Sci 1022:50-54.
73. Tan DJ, Bai RK, Wong LJ. 2002. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res 62:972-976. (Pubitemid 34160271)
74. Tong BC, Ha PK, Dhir K, Xing M, Westra WH, Sidransky D, Califano JA. 2003. Mitochondrial DNA alterations in thyroid cancer. J Surg Oncol 82:170-173.
75. Trejo-Becerril C, Pérez-Cárdenas E, Treviño-Cuevas H, Taja-Chayeb L, García-López P, Segura-Pacheco B, Chávez-Blanco A, Lizano-Soberon M, González-Fierro A, Mariscal I, Wegman-Ostrosky T, Dueñas-González A. 2003. Circulating nucleosomes and response to chemotherapy: An in vitro, in vivo and clinical study on cervical cancer patients. Int J Cancer 104:663-668.
76. Tseng LM, Yin PH, Chi CW, Hsu CY, Wu CW, Lee LM, Wei YH, Lee HC. 2006. Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes Chromosomes Cancer 45:629-638.
77. Umetani N, Kim J, Hiramatsu S, Reber HA, Hines OJ, Bilchik AJ, Hoon DS. 2006. Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: Direct quantitative PCR for ALU repeats. Clin Chem 52:1062-1069.
78. Van Trappen PO, Cullup T, Troke R, Swann D, Shepherd JH, Jacobs IJ, Gayther SA, Mein CA. 2007. Somatic mitochondrial DNA mutations in primary and metastatic ovarian cancer. Gynecol Oncol 104:129-133.
79. Vermulst M, Bielas JH, Kujoth GC, Ladiges WC, Rabinovitch PS, Prolla TA, Loeb LA. 2007. Mitochondrial point mutations do not limit the natural lifespan of mice. Nat Genet 39:540-543.
80. Vermulst M, Wanagat J, Kujoth GC, Bielas JH, Rabinovitch PS, Prolla TA, Loeb LA. 2008. DNA deletions and clonal mutations drive premature aging in mitochondrial mutator mice. Nat Genet 40:392-394.
81. Wada T, Tanji N, Ozawa A, Wang J, Shimamoto K, Sakayama K, Yokoyama M. 2006. Mitochondrial DNA mutations and 8-hydroxy-20-deoxyguanosine Content in Japanese patients with urinary bladder and renal cancers. Anticancer Res 26(5A):3403-3408.
82. Wallace DC. 1999. Mitochondrial diseases in man and mouse. Science 283:1482-1488.
83. Wang CY, Wang HW, Yao YG, Kong QP, Zhang YP. 2007a. Somatic mutations of mitochondrial genome in early stage breast cancer. Int J Cancer 121:1253-1256.
84. Wang Y, Xue WC, Liu VW, Ngan HY. 2007b. Detection of mosaic pattern of mitochondrial DNA alterations in different populations of cells from the same endometrial tumor. Mitochondrion 7(1-2):171-175.
85. Wu CW, Yin PH, Hung WY, Li AF, Li SH, Chi CW, Wei YH, Lee HC. 2005. Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer. Genes Chromosomes Cancer 44:19-28.
86. Wu TL, Zhang D, Chia JH, Tsao KH, Sun CF, Wu JT. 2002. Cell-free DNA: Measurement in various carcinomas and establishment of normal reference range. Clin Chim Acta 321(1-2):77-87.
87. Wunderlich V, Schutt M, Bottger M, Graffi A. 1970. Preferential alkylation of mitochondrial deoxyribonucleic acid by N-methyl-N-nitrosourea. Biochem J 118:99-109.
88. Wunderlich V, Tetzlaff I, Graffi A. 1972. Studies on nitrosodimethylamine: Preferential methylation of mitochondrial DNA in rats and hamsters. Chem Biol Interact 4:81-89.
89. Yeh JJ, Lunetta KL, van Orsouw NJ, Moore FD Jr., Mutter GL, Vijg J, Dahia PL, Eng C. 2000. Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours. Oncogene 19:2060-2066. (Pubitemid 30229419)
90. Zachariah RR, Schmid S, Buerki N, Radpour R, Holzgreve W, Zhong X. 2008. Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors. Obstet Gynecol 112:843-850.
91. Zheng L, Dai H, Zhou M, Li M, Singh P, Qiu J, Tsark W, Huang Q, Kernstine K, Zhang X, Lin D, Shen B. 2007. Fen1 mutations result in autoimmunity, chronic inflammation and cancers. Nat Med 13:812-819.
92. Zhu W, Qin W, Bradley P, Wessel A, Puckett CL, Sauter ER. 2005. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid. Carcinogenesis 26:145-152.